GlassScriptPhysician profile
Gregory J Kaye
NPI 1023079126
$4,929.75
in general payments reported to CMS, 2019-2025
19 companies · $617 in 2025
The $617 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $492 · 2021: $536 · 2022: $750 · 2023: $1,147 · 2024: $562 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,326.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,228.29 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $478.02 | 2019-2025 | Cequa, Xelpros |
| Johnson & Johnson Vision Care, INC. | $448.28 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $447.61 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $426.86 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $383.43 | 2019-2021 | |
| Abbvie INC. | $282.07 | 2022-2025 | |
| Oyster Point Pharma, INC. | $251.76 | 2022-2024 | Tyrvaya |
| Coopervision INC. | $242.69 | 2019-2024 | Clariti Contact Lens, Myday Contact Lens |
| Dompe US, INC. | $122.51 | 2023-2025 | Oxervate |
| Biotissue Holdings INC. | $111.24 | 2021-2023 | |
| Allergan, INC. | $104.90 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $87.92 | 2019-2025 | Tecnis Iol |
| Kala Pharmaceuticals, INC. | $84.26 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $70.64 | 2025 | Xdemvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $66.11 | 2019 | |
| Rayner Intraocular Lenses Limited | $48.55 | 2022 | |
| Thea Pharma INC. | $29.61 | 2025 | Iyuzeh |
| Tearlab Corp | $15.00 | 2023 | Tearlab Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kaye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.